• Completed clinical trial of Neuraceq^TM.
• Completed Phase I clinical trial of XTR003 and XTR004, and initiated Phase II clinical trial.
• Closed CNY ¥640m series D&D+ financing round co-invested by CICC, China Life Private Equity, Centurium Capital and many other well-known investment institutions.
• Achieve strategic collaboration with Biogen, JOINN, United Imaging, DualityBio respectively.